Senior Scientist - Formulation Development at Acadia Pharmaceuticals

Sacramento, California, United States

Acadia Pharmaceuticals Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

  • Ph.D. or Postgraduate degree in Pharmacy, Pharmaceutical Sciences, Chemistry, or a related field
  • 3+ years of hands-on experience in sterile/Injectable pharmaceutical formulation development. (Strong candidates with combinations of education and experience will be considered.)
  • Strong understanding of formulation principles, excipients, and drug delivery systems
  • Hands-on experience with various formulation techniques and equipment
  • Proven track record of successful formulation development and commercialization
  • Experience with statistical design of experiments (DOE) and data analysis
  • Proven track record of successful formulation development for various sterile dosage forms
  • Strong leadership, project management, and organizational skills
  • Expertise in complex injectable and sterile dosage form development
  • Demonstrated ability to conduct independent research and problem-solving
  • Must live in or be (near Sacramento, CA - inferred from incomplete text)

Responsibilities

  • Lead the design, development, and optimization of complex injectable and sterile dosage forms
  • Develop and implement robust formulation development strategies aligned with regulatory guidelines (e.g., Quality by Design, FDA)
  • Apply scientific fundamentals and creative problem-solving skills to solve complex technical issues
  • Conduct rigorous experimental design studies (e.g., factorial design) to achieve project objectives
  • Collaborate closely with cross-functional teams, including Technical Services, Operations, and Regulatory Affairs
  • Define scope, timeline, and resource needs of functional activities and keep team on schedule
  • Participate in evaluation of new product opportunities
  • Ensure timely and high-quality documentation for regulatory submissions
  • Stay updated with all FDA and regulatory requirements/guidelines
  • Provide mentorship and leadership to team members
  • Stay up to date with the latest scientific advancements in formulation development and applying new technologies to improve product performance
  • Author and review technical reports, protocols, and regulatory documents
  • Additional duties and assignments as needed

Skills

Formulation Development
Injectable Dosage Forms
Sterile Dosage Forms
Drug Optimization
Pharmaceutical R&D
Dosage Form Design

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters
1993Year Founded
$813.4MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Paid Vacation
Paid Holidays
Paid Sick Leave
Paid Parental Leave
Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.
Potential clinical trial delays could affect drug approval timelines.
Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
The company has a strong R&D foundation, developing innovative small molecule drugs.
Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI